Seroquel trial set, Astra may seek early judgment
LONDON (Reuters) - AstraZeneca said on Wednesday a U.S. court would hear its patent case against Teva and Sandoz , which are seeking to make a generic version of schizophrenia drug Seroquel, from August 11.
<p><img src="http://feeds.reuters.com/~a/reuters/businessNews?i=Edrc6r" border="0"></img> (http://feeds.reuters.com/~a/reuters/businessNews?a=Edrc6r)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/businessNews?i=vrMY8EF" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=vrMY8EF) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=CUFQnkf" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=CUFQnkf) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=f9GsSaf" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=f9GsSaf)
</div><img src="http://feeds.reuters.com/~r/reuters/businessNews/~4/250013236" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/250013236/idUSL1273248120080312